Research profile
TB-500
This profile refers to the LKKTETQ fragment of thymosin beta-4. The FDA briefing evaluated a proposed use in wound healing.
- Limited human evidence
- Evaluation only
Amnavero
TB-500
What the research found
FDA staff reviewed evidence about this specific fragment. Results for the full-length thymosin beta-4 protein concern a different molecule.
What remains uncertain
A healing benefit and a safety profile in humans remain unestablished for the fragment.